CD9

CD9

CD9 Molekülinformation

Molecule Name
CD9 antigen
Molekülalias
CD9,MIC3,TSPAN29,GIG2,MRP1,BTCC1,DRAP27,5H9
Drug Development Progress
Anzahl der klinischen Arzneimittel1
Anzahl der inverkehr gebrachten Arzneimittel0
Höchste Forschungs- und EntwicklungsphasePhase 1 Clinical
Target-Alias
Motility Related Protein-1,Leukocyte Antigen MIC3,Tetraspanin-29,5H9 Antigen,CD9 Molecule,TSPAN29,MRP-1,Cell Growth-Inhibiting Gene 2 Protein,MIC3,Motility-Related Protein,P24,BA-2/P24 Antigen,Antigen CD9,TSPAN-29,Tspan-29,DRAP-27,BTCC-1,CD9,BA2
Molekülhintergrund
CD9 antigen is also known as tetraspanin-29 (TSPAN29), 5H9 antigen, Leukocyte antigen MIC3 (MIC3), Motility-related protein, is a multi-pass membrane protein which belongs to the tetraspanin (TM4SF) family or the transmembrane 4 superfamily. CD9 is a cell surface glycoprotein that is known to complex with integrins and other transmembrane 4 superfamily proteins. TSPAN29 is found on the surface of exosomes. MIC3 Involved in platelet activation and aggregation, regulates paranodal junction formation and also Involved in cell adhesion, cell motility and tumor metastasis. CD9 antigen also seems to be a key part in the egg-sperm fusion during mammalian fertilization

CD9 Produktliste

Species
  • Human(4)
Tag
  • -(1)
  • His Tag(1)
  • His Tag & Avi Tag(1)
  • His Tag & Flag Tag(1)
Host
  • HEK293(4)
Conjugate
  • Unconjugated(3)
  • Biotin-labeled(1)
Grade
  • RUO(4)
Low Endotoxin
  • No(4)
MoleculeCat. No.Product NameArtHostStructurePurityActivitySize&PriceAdd to Cart
CD9
Human CD9 Protein, His Tag
Human
HEK293
SDS-PAGE

$300.00

20ug
CD9
Human CD9 Full Length Protein, Flag,His Tag (Detergent)
Human
HEK293
ELISASPR

$805.00

20ug
CD9
Human CD9 Full Length Protein (VLP)
Human
HEK293
HPLC
ELISAIdentity

$620.00

20ug
CD9
Avitag
CD9-H82Ea
Biotinylated Human CD9 Protein, His,Avitag™
Human
HEK293
SDS-PAGE

$360.00

25ug
You Have Viewed 1-4 Of 4 Results
  • 1

Can’t find what you need?

Submit your requirements and our technical
team will help.

Asset Licensing Opportunity
Resources

Klinische Arzneimittelinformation

Englischer NameForschungscodeForschungsphaseFirmaIndikationenKlinische Studie
KBA-1412KBA-1412; KBA1412; AT-1412Phase 1 ClinicalAimm Therapeutics
Solid tumours
Details
Customer Reviews